Video

Q&A With Colleen Kelly, MD, From Brown Alpert Medical School: Fecal Microbiota Transplant Moves Into Mainstream Treatment for C-Difficie

Author(s):

What once was viewed to be an unscientific approach to help treat C-difficile, fecal microbiota transplant has become not only an accepted method of treatment, but also the preferred method in many patients.

What once was viewed to be an unscientific approach to help treat C-difficile, fecal microbiota transplant has become not only an accepted method of treatment, but also the preferred method in many patients.

Colleen Kelly discussed the procedure during the American College of Physicians Internal Medicine meeting in Boston. As the procedure has developed it has become easier for doctors outside of gastroenterology to handle the transplants in some cases. Kelly said it is important that the donor for the transplant is properly screened to ensure ultimate success.

Related Videos
Marcelo Kugelmas, MD | Credit: South Denver Gastroenterology
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
© 2024 MJH Life Sciences

All rights reserved.